Skip to main content
Log in

No difference in relevant potential allergens in SPF-containing facial moisturizers: implications in frontal fibrosing alopecia

  • Short Communication
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Background

Although controversial, it has been proposed that the use of leave-on facial skin care products, namely daily facial moisturizers with sun protection factor (SPF), is associated with frontal fibrosing alopecia (FFA). In accordance, several authors have previously reported on patch testing results in cross-sectional studies of patients with FFA.

Aims

The aim was to survey the top-selling facial moisturizers for the prevalence of potential allergens identified in FFA patient patch testing and to then distinguish if those moisturizers containing SPF were statistically more likely to have relevant potential allergens than moisturizers without SPF.

Methods

Three online retailers were surveyed for the best-selling facial moisturizers, and ingredient lists were reviewed for allergens found in FFA-patient patch testing and fragrance and botanical cross-reactors.

Results

Out of 100 unique facial moisturizers, 87 contained at least one potential allergen identified in previous patch testing results of FFA patients. There was no significant difference in the prevalence of indicated allergens in facial moisturizers with SPF in comparison to those without SPF.

Conclusion

It does not appear that the presence of additional identified allergens in facial moisturizers with SPF explains the reported association with FFA. Further prospective, comparative studies are necessary to understand the potential role of personal cosmetic products in the development of FFA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. MacDonald A, Clark C, Holmes S. Frontal fibrosing alopecia: a review of 60 cases. J Am Acad Dermatol. 2012;67(5):955–61.

    Article  PubMed  Google Scholar 

  2. Kossard S. Postmenopausal frontal fibrosing alopecia: scarring alopecia in a pattern distribution. Arch Dermatol. 1994;130(6):770–4.

    Article  CAS  PubMed  Google Scholar 

  3. Aldoori N, Dobson K, Holden CR, et al. Frontal fibrosing alopecia: possible association with leave-on facial skin care products and sunscreens; a questionnaire study. Br J Dermatol. 2016;175(4):762–7.

    Article  CAS  PubMed  Google Scholar 

  4. Cranwell WC, Sinclair R. Frontal fibrosing alopecia: regrowth following cessation of sunscreen on the forehead. Australas J Dermatol. 2019;60(1):60–1.

    Article  PubMed  Google Scholar 

  5. Cranwell WC, Sinclair R. Sunscreen and facial skincare products in frontal fibrosing alopecia: a case-control study. Br J Dermatol. 2019;180(4):943–4.

    Article  CAS  PubMed  Google Scholar 

  6. Debroy Kidambi A, Dobson K, Holmes S, et al. Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens. Br J Dermatol. 2017;177(1):260–1.

    Article  CAS  PubMed  Google Scholar 

  7. Moreno-Arrones OM, Saceda-Corralo D, Rodrigues-Barata AR, et al. Risk factors associated with frontal fibrosing alopecia: a multicentre case-control study. Clin Exp Dermatol. 2018. https://doi.org/10.1111/ced.13785.

    Article  PubMed  Google Scholar 

  8. Donati A. Frontal fibrosing alopecia and sunscreens: cause or consequence? Br J Dermatol. 2016;175(4):675–6.

    Article  CAS  PubMed  Google Scholar 

  9. Ishizaki K, Yamada A, Yoh K, et al. Th1 and type 1 cytotoxic T cells dominate responses in T-bet overexpression transgenic mice that develop contact dermatitis. J Immunol Baltim Md. 2007;178(1):605–12.

    CAS  Google Scholar 

  10. Gay-Mimbrera J, Ruano J, Pavel AB, et al. 1322 Molecular profiling of frontal fibrosing alopecia (FFA) reveals TH1 and JAK-STAT up-regulation with no suppression of hair keratins [abstract]. J Invest Dermatol. 2018;138(5 Suppl):S225.

    Article  Google Scholar 

  11. Rocha VB, Donati A, Contin LA, et al. Photopatch and patch testing in 63 frontal fibrosing alopecia patients: a case series. Br J Dermatol J. 2018;179(6):1402–3.

    Article  CAS  Google Scholar 

  12. Aerts O, Bracke A, Goossens A, et al. Titanium dioxide nanoparticles and frontal fibrosing alopecia: cause or consequence? J Eur Acad Dermatol Venereol. 2019;33(1):e45–6.

    Article  CAS  PubMed  Google Scholar 

  13. DiNardo JC, Downs CA. Dermatological and environmental toxicological impact of the sunscreen ingredient oxybenzone/benzophenone-3. J Cosmet Dermatol. 2018;17(1):15–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maryanne M. Senna.

Ethics declarations

Funding

None.

Conflict of interest

D.H. Marks, A. Manatis-Lornell, D. Hagigeorges, J. Yu, and M.M. Senna have no conflicts of interest to report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marks, D.H., Manatis-Lornell, A., Hagigeorges, D. et al. No difference in relevant potential allergens in SPF-containing facial moisturizers: implications in frontal fibrosing alopecia. Drugs Ther Perspect 35, 347–349 (2019). https://doi.org/10.1007/s40267-019-00636-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-019-00636-6

Navigation